Butte

Butte, Montana 59701

0 studies enrolling now · 3 studies all time

What they study most

C. Diff, C. Difficile, CDI, Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence, FMT, Fecal Microbiota, Fecal Transplant, Recurrent C. Diff, Recurrent CDI, Recurrent Clostridium Difficile Infection, rCDI

Studies at this site

• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff — Completed
• Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection — Completed
• A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) — Completed